Back
Relay Therapeutics, Inc. Stock Predictions
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
65
RLAY
Relay Therapeutics, Inc.
Last Price:
$8.41
Seasonality Move:
-13.11%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiRelay Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Relay Therapeutics, Inc. has on average historically fallen by 23.6% based on the past 5 years of stock performance.
-
Relay Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Relay Therapeutics, Inc. Stock Undervalued?The current Relay Therapeutics, Inc. [RLAY] share price is $8.40. The Score for RLAY is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
RLAY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Relay Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Relay Therapeutics, Inc. has on average historically fallen by 23.6% based on the past 5 years of stock performance.
Relay Therapeutics, Inc. Stock Rating
Buy
65
Relay Therapeutics, Inc. (RLAY)
is a Buy
Is Relay Therapeutics, Inc. overpriced?
-
Relay Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Relay Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
relaytx.com
52-Week Data
52-Week High:
9.04
52-Week Low:
1.78
Prediction Charts
Market Cap:
1.5B
Price in USD:
8.40
Volume:
5.8M
Beta:
1.72
Technical Analysis
SMA50:
7.14
SMA100:
5.65
SMA200:
4.40
52-Wk Change:
97.18%
Stock Predictions
-
Is Relay Therapeutics, Inc. stock public?Yes, Relay Therapeutics, Inc. is a publicly traded company.
-
What is the Relay Therapeutics, Inc. stock quote today?The Relay Therapeutics, Inc. stock price is 8.40 USD today.
-
How to buy Relay Therapeutics, Inc. stock online?You can buy Relay Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 7.40 | 7.49 | 7.61 | 7.23 |
| Dec-3 | 7.55 | 7.83 | 7.92 | 7.53 |
| Dec-4 | 7.73 | 8.00 | 8.09 | 7.69 |
| Dec-5 | 8.03 | 7.68 | 8.13 | 7.58 |
| Dec-8 | 7.84 | 7.63 | 7.95 | 7.56 |
| Dec-9 | 7.78 | 7.58 | 8.00 | 7.55 |
| Dec-10 | 7.57 | 7.59 | 7.81 | 7.42 |
| Dec-11 | 7.61 | 7.79 | 7.89 | 7.55 |
| Dec-12 | 8.60 | 8.03 | 8.70 | 7.71 |
| Dec-15 | 8.08 | 8.48 | 8.53 | 8.01 |
| Dec-16 | 8.52 | 8.48 | 9.04 | 8.41 |
| Dec-17 | 8.40 | 8.03 | 8.50 | 7.95 |
| Dec-18 | 8.16 | 8.13 | 8.38 | 7.96 |
| Dec-19 | 8.19 | 8.40 | 8.69 | 8.14 |
Relay Therapeutics, Inc. Earnings
Relay Therapeutics, Inc. Earnings Report: Per Share Relay Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Relay Therapeutics, Inc. Forecast Revenue Growth
Relay Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Relay Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.14 per share.
* Relay Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.